The expression of MDM2 in gastrointestinal stromal tumors: immunohistochemical analysis of 35 cases.

Boubacar EfaredGabrielle Atsame-EbangLayla TahiriIbrahim Sory SidibéFatimazahra ErregadNawal HammasSamia ArifiIhsane MelloukiAbdelmalek OusaddenKhalid MazazHinde El FatemiLaila Chbani

Published in: BMC clinical pathology (2018)

The current study suggests that MDM2 immunohistochemical expression is a negative histoprognostic factor in GIST with a statistically significant correlation with metastasis.

Keyphrases

poor prognosis
binding protein